NGD (NGD)
Quantitative Summary
DeterministicFinancial health metrics are strong: Piotroski 7/9, Altman Z 4.3 (above 3.0 safe zone threshold).
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe fundamental economics of NGD demonstrate a robust capital allocation efficiency, evidenced by an ROIC-WACC spread of +11.7%, indicating the company generates returns significantly exceeding its cost of capital. This high-quality profile is further reinforced by a Piotroski F-Score of 7/9 and a Beneish M-Score of -2.32, suggesting strong financial health with minimal earnings manipulation risk. The DuPont decomposition reveals that this performance is driven primarily by exceptional profitability rather than leverage or asset turnover; specifically, net margins at 58.1% and gross margins of 53.2% are the primary engines fueling an ROE well above industry norms. Additionally, revenue growth accelerating to 59.7% YoY aligns with these margin expansions, creating a compounding value creation scenario typical of high-conviction small-cap opportunities.
Despite the superior operational metrics, valuation multiples present a divergence from intrinsic worth. The current P/E ratio stands at 28.4x, which appears elevated relative to the underlying cash flow generation implied by the DCF analysis showing a fair value of $7. This discrepancy suggests the market is pricing in aggressive future growth assumptions that may not be fully supported by historical trajectory or conservative terminal values. While the high margin environment allows for significant earnings leverage, the current multiple leaves little room for error if revenue expansion moderates from its recent 59.7% pace, potentially compressing returns over the medium term as expectations normalize around a more sustainable growth rate.
The risk profile appears mitigated by an Altman Z-Score of 4.3, which places the firm in a "safe zone" with low bankruptcy probability, yet the gap between current market pricing and DCF-derived fair value introduces downside volatility if macroeconomic headwinds impact high-margin operations. Without specific sector peer data or insider transaction records to contextualize the premium valuation, investors must weigh whether the 28.4x multiple adequately compensates for the uncertainty surrounding long-term growth sustainability versus the safety provided by strong balance sheet metrics and clean earnings quality indicators.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
InteractiveSensitivity Matrix
| TG ↓ / WACC → | 13.4% | 15.4% | 17.4% |
|---|---|---|---|
| 2% | $8 | $7 | $6 |
| 3% | $9 | $7 | $6 |
| 4% | $10 | $8 | $6 |
Center = base case. Green = >10% upside, Red = >10% downside vs —.
Pre-computed DCF: WACC=15.3%, terminal growth 3%. Fair value $7 (+0.0%). Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
NGD Capital Efficiency
How efficiently does NGD convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
NGD converts 26% of its EBITDA into free cash flow, a moderate conversion rate — significant EBITDA is consumed by capital expenditures, working capital changes, or interest payments. The 74% reinvestment rate signals aggressive capacity expansion. The positive ROIC-WACC spread of 11.7% confirms that reinvested capital creates shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-03-20 | 691 | $9.08 | $6,274.28 |
| 2026-03-17 | 4,169 | $10.32 | $43,024.08 |
| 2026-03-13 | 325,074 | $10.72 | $3.5M |
| 2026-03-12 | 452 | $11.05 | $4,994.6 |
| 2026-03-10 | 9,444 | $11.17 | $105,489.48 |
| 2026-03-04 | 2,675 | $11.91 | $31,859.25 |
| 2026-03-03 | 56,817 | $13.33 | $757,370.61 |
| 2026-03-02 | 1,860 | $13.42 | $24,961.2 |
| 2026-02-26 | 5,194 | $12.19 | $63,314.86 |
| 2026-02-25 | 5,314 | $12.25 | $65,096.5 |
| 2026-02-23 | 48,800 | $12.22 | $596,336 |
| 2026-02-19 | 2,831 | $11.22 | $31,763.82 |
| 2026-02-18 | 200 | $10.77 | $2,154 |
| 2026-02-17 | 54,373 | $11.06 | $601,365.38 |
| 2026-02-13 | 900 | $10.33 | $9,297 |
| 2026-02-11 | 70 | $11.32 | $792.4 |
| 2026-02-04 | 10 | $10.49 | $104.9 |
| 2026-02-02 | 53,276 | $10.03 | $534,358.28 |
| 2026-01-29 | 989,222 | $12.57 | $12.4M |
| 2026-01-28 | 100 | $12.58 | $1,258 |
| 2026-01-27 | 20,833 | $12.50 | $260,412.5 |
| 2026-01-23 | 92,821 | $12.62 | $1.2M |
| 2026-01-20 | 40,780 | $11.06 | $451,026.8 |
| 2026-01-13 | 33,636 | $10.55 | $354,859.8 |
| 2026-01-09 | 1,727 | $9.56 | $16,510.12 |
| 2026-01-08 | 537 | $9.36 | $5,026.32 |
| 2026-01-07 | 37 | $9.52 | $352.24 |
| 2026-01-02 | 19,000 | $8.71 | $165,490 |
| 2025-12-31 | 19,165 | $8.81 | $168,843.65 |
| 2025-12-30 | 6,131 | $8.89 | $54,504.59 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare NGD to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.